In swine grower-finisher herds where drinking-water medication is selected during porcine respiratory disease complex and enteric disease events, Huangqin Jiaogulan Powder is incorporated into a water-soluble premix at 0.5–1.0 kg per 1,000 L of finished drinking water, with the medicinal stock first dispersed in 100–200 L of ambient water before injection through a proportional dosing pump. Quality release follows Regulation (EU) 2019/6 for veterinary medicinal products where therapeutic claims are made, and Regulation (EC) No 1831/2003 where the material is used as a feed additive or complementary feed; manufacturing is conducted under GMP Part II or an equivalent feed hygiene system such as FAMI-QS. The production process is non-sterile oral powder processing: the extract is dry-blended with dextrose monohydrate or lactose in a 500 L ribbon mixer for 15 min, wet-granulated with a 2.0% povidone K30 solution in a high-shear granulator at impeller speed 300 rpm and chopper speed 2,000 rpm for 90 s, tray-dried at 40–45°C to loss on drying ≤ 1.5%, and sized through a 0.5 mm conical mill. Analytical release includes identity by HPTLC and assay of baicalin and gypenosides by HPLC-UV under VICH GL2, heavy metals by USP <232>/<233>, and microbial enumeration by USP <2021>; bulk water activity is maintained at ≤ 0.60 to prevent caking in storage. A process-sensitive boundary is baicalin precipitation when the reconstituted drinking water pH falls below 5.5; therefore trisodium citrate is added at 0.2–0.5% of powder mass to keep final water pH at 6.8–7.2. Simultaneous use of acidifiers in the same header line is avoided because precipitate occludes nipple drinkers and cuts dispensed dose. Terminal forms include 100 g, 500 g and 1 kg water-soluble powder sachets, 5 kg HDPE jars, and 25 kg PE-lined fibre drums.

Why Does Pelletising Above 75°C Reduce Gypenoside Recovery in Broiler Premix Granules?

Feed mills that add the multibotanical extract directly into pelleted broiler rations before the conditioner encounter a measurable thermal degradation window when meal temperature exceeds 75°C. In production-scale audits of a 5 t h⁻¹ conditioner-pelletiser line, gypenoside recovery after conditioning at 85°C for 45 s can decline by 8–15% relative to unprocessed premix when meal moisture is 16–17%. The carrier premix is dosed at 5–10 kg per tonne of final feed, corresponding to 1.0–2.0 kg per tonne of active powder in complete broiler feed; mixing homogeneity is verified in a double-ribbon mixer for 10 min with tracer analysis and a target coefficient of variation CV ≤ 5%. Compliance is anchored to Regulation (EC) No 1831/2003, Regulation (EC) No 183/2005, FAMI-QS and GMP+ BA2 feed safety assurance, with assay methodology validated under VICH GL2, mycotoxin screening by LC-MS/MS according to ISO 16050, total aerobic count by ISO 4833-1, and Salmonella absence by ISO 6579-1. To limit thermal loss, the preferred production route is post-conditioning liquid suspension spraying after pellet cooling rather than dry addition into the mixer; if dry addition is unavoidable, the conditioner temperature is capped at ≤ 75°C and retention time is reduced to ≤ 20 s. Terminal finished products include 2–3 mm broiler grower and finisher pellets, 1–2 mm crumbled starter feed, and 5 kg or 25 kg multiwall paper sacks with PE liners.

Aseptic Filtration Envelope for Mixed Saponin-Rich Injectable Solutions

Sterile veterinary injectable solutions containing Huangqin Jiaogulan Powder are constrained simultaneously by baicalin solubility and saponin foaming behaviour. The extraction liquor is prepared in Water for Injection at 60–70°C, adjusted to pH 6.5–7.0 with sodium hydroxide or tromethamine, clarified through 0.45 μm polyethersulfone depth media, and sterilised by final filtration through a 0.22 μm PVDF capsule at differential pressure ≤ 0.8 bar. The active powder is incorporated at 5–10 mg mL⁻¹ total solids, with baicalin standardised to 0.5–1.0 mg mL⁻¹ in the finished solution. Regulatory compliance for this sterile route is governed by USP <71> sterility, USP <85> with bacterial endotoxin limit ≤ 0.5 EU mL⁻¹, VICH GL18 residual solvents, and ICH Q3D elemental impurity limits calculated on the daily dose. Terminal dosage forms are 10 mL and 20 mL amber borosilicate glass vials sealed with chlorobutyl rubber stoppers. Terminal autoclaving at 121°C for 15 min is not used because stability observations have shown baicalin reduction above 10% under that heat load, making aseptic filtration the defining commercial batch boundary. Production foam collapse during vacuum-assisted filtration is controlled by maintaining ≤ 0.5 bar differential pressure and limiting polysorbate concentration to ≤ 0.2% to avoid filter wetting inconsistency. Published stability data for this specific botanical injectable combination is limited; each batch is therefore supported by at least three pilot-scale aseptic fill runs before process validation.

Veterinary chewable tablets for companion animals using direct compression rather than wet granulation require the raw powder to exhibit tapped density above 0.6 g mL⁻¹ and a Hausner ratio ≤ 1.25 before a 19-station rotary tablet press can operate at 30 rpm without sticking or lamination. The active powder is loaded at 5–15% w/w of core tablet mass, with a typical 500 mg tablet containing 25–75 mg Huangqin Jiaogulan Powder alongside microcrystalline cellulose, dicalcium phosphate, crospovidone 2% w/w, colloidal silicon dioxide 0.5% w/w, and magnesium stearate 0.8% w/w. Compression force is maintained at 8–15 kN to achieve tablet hardness 60–90 N and friability ≤ 0.5%; blending is conducted in a 300 L bin blender at 12 rpm for 20 min. Release testing follows USP <905> for uniformity of dosage units, USP <1217> for tablet breaking force, USP <701> for disintegration, and VICH GL2 for assay validation; heavy metals are controlled by USP <232>/<233>. Because the botanical powder is hygroscopic, tableting environments above 60% RH require pre-drying at 40°C for 30 min or application of a film coat to prevent picking. Terminal forms include 30-tablet HDPE blisters, 60-tablet amber glass jars, and size 0 gelatin or HPMC capsules filled on a dosator machine at 20–30 g s⁻¹.

When Floating Extruded Fish Feed Is Selected, Post-Extrusion Coating Becomes the Only Thermally Stable Delivery Route

After pellet cooling on an extruded aquaculture line, the extract can be applied by vacuum coating because direct pre-extrusion addition to floating fish feed exposes baicalin and gypenosides to barrel temperatures of 110–130°C and moisture above 25%. Finfish feed is extruded through a twin-screw extruder at screw speed 300–400 rpm and die pressure 20–40 bar; pellets are dried to moisture ≤ 9%, then transferred to a vacuum coater where the extract is suspended in fish oil at 30–40°C and applied at 2–3% oil uptake. The addition rate in complete feed is 0.5–1.5 kg per tonne, while the intermediate premix carries 10–20 kg per tonne to maintain batch homogeneity after dilution. Compliance for this non-sterile aquaculture route is verified under Regulation (EC) No 183/2005, ISO 22000, FAMI-QS, and assay validation under VICH GL2; heavy metals are controlled by USP <232>/<233>, and microbial load by ISO 4833-1. Terminal finished products include 2–4 mm floating pellets for tilapia and carp, 1.5–2.0 mm sinking pellets for shrimp, and 25 kg polywoven sacks with moisture-proof liners.

In pre-ruminant calf rearing systems with automated milk replacer feeders, granulated Huangqin Jiaogulan Powder is formulated as a free-flowing dry granule at 0.5–1.0 mm particle size to prevent bridging in hoppers at high ambient humidity. The product is dosed at 1 g per calf per day for 5–7 days; in reconstituted milk replacer, the addition is 0.5–1.0 g L⁻¹ to maintain dispersion without nozzle clogging. Production consists of wet granulation with 2.5% povidone K30 in a high-shear processor, fluid-bed drying at 45–50°C to final moisture ≤ 2.0%, and application of a 2% ethylcellulose seal coat to limit hygroscopic uptake at 35% RH. Release follows USP <905> for dose uniformity, USP <701> disintegration, and VICH GL2 for assay validation; elemental impurities are controlled by USP <232>/<233>. Acidified milk replacer below pH 4.5 is avoided because baicalin precipitates and settles in the feeder tubing. Terminal forms are 20 g single-dose sachets, 100 g HDPE jars with desiccant canisters, and 500 g PET/PE laminate pouches.